Ninety One North America’s Pediatrix Medical MD Stock Holding History

Ninety One North America’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-125,235	Closed	-$8.69M	–	82
2017 Q1	$8.69M	Buy	125,235 +5,860	+5%	+$407K	1.64%	33
2016 Q4	$7.96M	Buy	119,375 +6,876	+6%	+$447K	1.19%	44
2016 Q3	$7.45M	Buy	112,499 +3,686	+3%	+$252K	1%	54
2016 Q2	$7.88M	Sell	108,813 -6,963	-6%	-$479K	1.16%	50
2016 Q1	$7.48M	Buy	115,776 +4,396	+4%	+$292K	1.24%	41
2015 Q4	$7.98M	Buy	111,380 +37,668	+51%	+$2.79M	1.41%	38
2015 Q3	$5.66M	Sell	73,712 -12,784	-15%	-$1.03M	1.43%	37
2015 Q2	$6.41M	Sell	86,496 -12,615	-13%	-$908K	2.06%	20
2015 Q1	$7.19M	Buy	99,111 +89,438	+925%	+$6.22M	2.23%	21
2014 Q4	$639K	Buy	+9,673	New	+$590K	0.19%	83

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Ninety One North America's MD Position: Q2 2017 in Review

Ninety One North America sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 125,235 shares — an estimated $8.69M sold.

Ninety One North America first reported a position in MD in Q4 2014 and held it in 10 quarters. The position peaked at $8.69M in Q1 2017. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

Ninety One North America reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
Ninety One North America sold 125,235 Pediatrix Medical shares in Q2 2017, an estimated $8.69M.
Ninety One North America first reported a position in Pediatrix Medical in Q4 2014 and held it in 10 quarters.
Ninety One North America's Pediatrix Medical position peaked at $8.69M in Q1 2017.
332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on Ninety One North America's 13F filing for Q2 2017, filed 11 Aug 2017.